Suppr超能文献

自闭症谱系障碍的神经反馈。

Neurofeedback in autism spectrum disorders.

机构信息

LWL-University Hospital for Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics of the Ruhr University Bochum, Hamm, Germany.

出版信息

Dev Med Child Neurol. 2011 Nov;53(11):986-93. doi: 10.1111/j.1469-8749.2011.04043.x. Epub 2011 Jul 14.

Abstract

AIM

To review current studies on the effectiveness of neurofeedback as a method of treatment of the core symptoms of autism spectrum disorders (ASD).

METHOD

Studies were selected based on searches in PubMed, Ovid MEDLINE, EMBASE, ERIC, and CINAHL using combinations of the following keywords: 'Neurofeedback' OR 'EEG Biofeedback' OR 'Neurotherapy' OR 'Mu-Rhythm' OR 'SMR' AND 'Autism' OR 'Autism Spectrum Disorder' OR 'Pervasive Developmental Disorder'.

RESULTS

The existing evidence does not support the use of neurofeedback in the treatment of ASD. Studies with outcomes in favour of neurofeedback might be showing an improvement in comorbid attention-deficit-hyperactivity disorder symptoms rather than a true improvement in core ASD symptoms.

INTERPRETATION

Limitations of this review are those inherent in the studies available, including small sample size, short duration, variable diagnostic criteria, and insufficient control interventions, all causing a lack of generalizability.

摘要

目的

综述神经反馈作为自闭症谱系障碍(ASD)核心症状治疗方法的有效性的现有研究。

方法

通过在 PubMed、Ovid MEDLINE、EMBASE、ERIC 和 CINAHL 中使用以下关键词的组合进行搜索,选择研究:“Neurofeedback”或“EEG 生物反馈”或“Neurotherapy”或“Mu-Rhythm”或“SMR”以及“Autism”或“Autism Spectrum Disorder”或“Pervasive Developmental Disorder”。

结果

现有证据不支持将神经反馈用于 ASD 的治疗。支持神经反馈的研究结果可能表明共患注意缺陷多动障碍症状有所改善,而不是 ASD 核心症状的真正改善。

解释

本综述的局限性在于现有研究的固有局限性,包括样本量小、持续时间短、诊断标准不同和对照干预不足,所有这些都导致了缺乏普遍性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验